205 related articles for article (PubMed ID: 33068555)
21. Proton magnetic resonance spectroscopy in subjects at risk for schizophrenia.
Jessen F; Scherk H; Träber F; Theyson S; Berning J; Tepest R; Falkai P; Schild HH; Maier W; Wagner M; Block W
Schizophr Res; 2006 Oct; 87(1-3):81-8. PubMed ID: 16842971
[TBL] [Abstract][Full Text] [Related]
22. Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study.
Sigmundsson T; Maier M; Toone BK; Williams SC; Simmons A; Greenwood K; Ron MA
Schizophr Res; 2003 Nov; 64(1):63-71. PubMed ID: 14511802
[TBL] [Abstract][Full Text] [Related]
23. 7T Proton Magnetic Resonance Spectroscopy of the Anterior Cingulate Cortex in First-Episode Schizophrenia.
Reid MA; Salibi N; White DM; Gawne TJ; Denney TS; Lahti AC
Schizophr Bull; 2019 Jan; 45(1):180-189. PubMed ID: 29385594
[TBL] [Abstract][Full Text] [Related]
24. N-acetylaspartate concentration in psychotic disorders: T2-relaxation effects.
Kuan E; Chen X; Du F; Ongur D
Schizophr Res; 2021 Jun; 232():42-44. PubMed ID: 34015554
[TBL] [Abstract][Full Text] [Related]
25. N-acetyl aspartate concentration in the anterior cingulate cortex in patients with schizophrenia: a study of clinical and neuropsychological correlates and preliminary exploration of cognitive behaviour therapy effects.
Premkumar P; Parbhakar VA; Fannon D; Lythgoe D; Williams SC; Kuipers E; Kumari V
Psychiatry Res; 2010 Jun; 182(3):251-60. PubMed ID: 20488677
[TBL] [Abstract][Full Text] [Related]
26. Low N-acetyl-aspartate and high choline in the anterior cingulum of recently abstinent methamphetamine-dependent subjects: a preliminary proton MRS study. Magnetic resonance spectroscopy.
Nordahl TE; Salo R; Possin K; Gibson DR; Flynn N; Leamon M; Galloway GP; Pfefferbaum A; Spielman DM; Adalsteinsson E; Sullivan EV
Psychiatry Res; 2002 Nov; 116(1-2):43-52. PubMed ID: 12426033
[TBL] [Abstract][Full Text] [Related]
27. Comparison of brain N-acetylaspartate levels and serum brain-derived neurotrophic factor (BDNF) levels between patients with first-episode schizophrenia psychosis and healthy controls.
Goto N; Yoshimura R; Kakeda S; Moriya J; Hayashi K; Ikenouchi-Sugita A; Umene-Nakano W; Hori H; Ueda N; Korogi Y; Nakamura J
Eur Psychiatry; 2011 Jan; 26(1):57-63. PubMed ID: 20434315
[TBL] [Abstract][Full Text] [Related]
28. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia.
O'Neill J; Levitt J; Caplan R; Asarnow R; McCracken JT; Toga AW; Alger JR
Neuroimage; 2004 Apr; 21(4):1781-9. PubMed ID: 15050598
[TBL] [Abstract][Full Text] [Related]
29. Nature of Glutamate Alterations in Schizophrenia: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies.
Merritt K; Egerton A; Kempton MJ; Taylor MJ; McGuire PK
JAMA Psychiatry; 2016 Jul; 73(7):665-74. PubMed ID: 27304221
[TBL] [Abstract][Full Text] [Related]
30. Glutamate and N-Acetylaspartate Alterations Observed in Early Phase Psychosis: A Systematic Review of Proton Magnetic Resonance Spectroscopy Studies.
Bissonnette JN; Francis AM; MacNeil S; Crocker CE; Tibbo PG; Fisher DJ
Psychiatry Res Neuroimaging; 2022 Apr; 321():111459. PubMed ID: 35183897
[TBL] [Abstract][Full Text] [Related]
31. Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis.
Kraguljac NV; Reid M; White D; Jones R; den Hollander J; Lowman D; Lahti AC
Psychiatry Res; 2012; 203(2-3):111-25. PubMed ID: 22981426
[TBL] [Abstract][Full Text] [Related]
32. [Proton magnetic resonance spectroscopy of prefrontal lobe and thalamus in schizophrenics: correlation with clinical characteristics].
Gan JL; Duan HF; Yang JM; Shi ZJ; Zhang DW; Jiang ZK; Gao CY; Wang ZJ
Zhonghua Yi Xue Za Zhi; 2011 Nov; 91(43):3034-9. PubMed ID: 22333054
[TBL] [Abstract][Full Text] [Related]
33. Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis.
Steen RG; Hamer RM; Lieberman JA
Neuropsychopharmacology; 2005 Nov; 30(11):1949-62. PubMed ID: 16123764
[TBL] [Abstract][Full Text] [Related]
34. Proton magnetic resonance spectroscopy of the anterior cingulate gyrus, insular cortex and thalamus in schizophrenia associated with idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome).
Yasukawa R; Miyaoka T; Mizuno S; Inagaki T; Horiguchi J; Oda K; Kitagaki H
J Psychiatry Neurosci; 2005 Nov; 30(6):416-22. PubMed ID: 16327875
[TBL] [Abstract][Full Text] [Related]
35. Striatal metabolic alterations in non-psychotic adolescent offspring at risk for schizophrenia: a (1)H spectroscopy study.
Keshavan MS; Dick RM; Diwadkar VA; Montrose DM; Prasad KM; Stanley JA
Schizophr Res; 2009 Nov; 115(1):88-93. PubMed ID: 19748228
[TBL] [Abstract][Full Text] [Related]
36. Glutamate, N-acetyl aspartate and psychotic symptoms in chronic ketamine users.
Stone JM; Pepper F; Fam J; Furby H; Hughes E; Morgan C; Howes OD
Psychopharmacology (Berl); 2014 May; 231(10):2107-16. PubMed ID: 24264567
[TBL] [Abstract][Full Text] [Related]
37. In Vivo Brain Glycine and Glutamate Concentrations in Patients With First-Episode Psychosis Measured by Echo Time-Averaged Proton Magnetic Resonance Spectroscopy at 4T.
Kim SY; Kaufman MJ; Cohen BM; Jensen JE; Coyle JT; Du F; Öngür D
Biol Psychiatry; 2018 Mar; 83(6):484-491. PubMed ID: 29031411
[TBL] [Abstract][Full Text] [Related]
38. Role of glia in prefrontal white matter abnormalities in first episode psychosis or mania detected by diffusion tensor spectroscopy.
Lewandowski KE; Du F; Fan X; Chen X; Huynh P; Öngür D
Schizophr Res; 2019 Jul; 209():64-71. PubMed ID: 31101514
[TBL] [Abstract][Full Text] [Related]
39. Metabolite abnormalities in psychosis risk: A meta-analysis of proton magnetic resonance spectroscopy studies.
Wang YM; Xiao YH; Xie WL
Asian J Psychiatr; 2020 Dec; 54():102220. PubMed ID: 32653847
[TBL] [Abstract][Full Text] [Related]
40. Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study.
Bertolino A; Callicott JH; Elman I; Mattay VS; Tedeschi G; Frank JA; Breier A; Weinberger DR
Biol Psychiatry; 1998 May; 43(9):641-8. PubMed ID: 9582997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
